Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



ALS drug Radicava now available in US pharmacies

A new treatment option for patients with amyotrophic lateral sclerosis (ALS) is now available in US pharmacies for the first time in 22 years. Radicava (edavarone), developed and manufactured by Mitsubishi Tanabe Pharma America, was approved by the US Food and Drug Administration (FDA) in May 2017....

Read More

5 Top Tips for Safe Medication Management

The number of prescriptions filled in the United States has risen from 2.4 billion 1997 to 4.4 billion in 2016, according to figures from Quintiles IMS. With a recent Consumer Reports survey showing more than half of Americans regularly take prescription medication, the need for organized and safe...

Read More

Vyxeos approval a 'welcome therapeutic advance for AML patients'

Vyxeos (daunorubicin and cytarabine) has been approved by the US Food and Drug Administration (FDA). It is the first treatment approved for patients with certain types of high-risk acute myeloid leukemia (AML). The drug, developed by Jazz Pharmaceuticals, is a fixed combination of two chemotherapy...

Read More

HCV treatment with 98% cure rate gets FDA nod

The US Food and Drug Administration (FDA) approved the hepatitis C virus (HCV) treatment Mavyret (glecaprevir, pibrentasvir), granting biopharmaceutical firm AbbVie Breakthrough Therapy Designation and Priority Review for the treatment of GT1 HCV patients not cured with prior direct-acting...

Read More

Merck diabetes drug Lusduna Nexvue gains tentative FDA approval

Pharmaceutical giant Merck has been granted tentative approval for Lusduna Nexvue (insulin glargine injection) 100 units/mL by the US Food and Drug Administration.  The follow-on biologic basal insulin comes in a pre-filled dosing device and will be used to treat patients with type 2...

Read More

Gilead's hepatitis C drug Vosevi gains FDA approval

A new hepatitis C virus (HCV) treatment is expected to appear in pharmacies soon following US Food and Drug Administration's (FDA) decision to approve Vosevi, an HCV treatment developed by Gilead Sciences, Inc. The drug was cleared to treat adults with chronic HCV genotypes 1-6 with no cirrhosis,...

Read More